Oxford BioDynamics Plc

Oxford BioDynamics Plc

OXBOF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$11.41M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Oxford BioDynamics PlcOxford BioDynamics Plc-0.3--689%-1.3

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$11.41 Million
Enterprise Value$13.18 Million
Earnings per Share$-0.01
Beta-0.15
Outstanding Shares3,803,731,481

Return

Return on Equity-689.08%ROE
Return on Assets-246.52%
Return on Invested Capital-297.70%

Valuation & Multiples

P/E Ratio-0.29P/E Ratio
PEG1.3PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue6.3
Enterprise Value to EBIT-0.61
Enterprise Value to Net Income-1
Total Debt to Enterprise0.33
Debt to Equity1.32Debt to Equity

Revenue Sources

No data

Next Earnings Call

Expected Date
January 26, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Oxford BioDynamics Plc

37 employees
CEO: Richard Compton

Oxford BioDynamics Plc operates as a biotechnology firm that specializes in identifying and advancing biomarkers, primarily for the pharmaceutical and biotechnology sectors across global markets, including the United States. Its flagship...